Paediatric Investigation Plan

The Paediatric Investigation Plan (PIP) is a document required by the EMA for all new medicines.

It defines the paediatric clinical development strategy, including planned studies and scientific justifications.

Its goal is to ensure that innovative medicines are also assessed for paediatric use, addressing children’s medical needs in a safe and evidence-based way.